DIN 02537443 — QUVIVIQ 50 MG
QUVIVIQ is a tablet of Daridorexant marketed by IDORSIA PHARMACEUTICALS LTD. The full Daridorexant monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02537443
- Brand name
- QUVIVIQ
- Active ingredient
- Daridorexant
- Strength
- 50 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- IDORSIA PHARMACEUTICALS LTD
- Health Canada status
- MARKETED
- Drug class
- Dual orexin receptor antagonist (hypnotic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.